TechCrunch· @TechCrunch · X·· 2 小时前AI 评分37
AI 导读
Intero Biosystems 正向制药商出售实验室培育的人体肠道,因监管机构推动动物试验替代方案,同时该初创公司寻求扩大生产并拓展其类器官技术。 https://spr.ly/6013BHH0gh
正文
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
https://spr.ly/6013BHH0gh
来源:TechCrunch · x.com